2025-10-15T10:42:24-05:00 2024-12-31 861065772 DELOITTE TAX LLP 695 TOWN CENTER DRIVE SUITE 1000 COSTA MESA CA 92626 990 2024-01-01 980593375 GAVI ALLIANCE GAVI 2024781050 CHEMIN DU POMMIER 40 GRANDSACONNEX GENEVA SZ 1218 FRANCOIS NOTE CHIEF FINANCIAL OFFICER 2024781050 2025-10-15 1 1 JOHN W SADOFF JR P00540589 7144367100 2025-10-15 2024 2025-03-06 01:10:19Z GAVI THE VACCINE ALLIANCE FRANCOIS NOTE CHEMIN DU POMMIER 40 GRANDSACONNEX GENEVA SZ 1218 2734373000 0 X GAVI.ORG X 2009 SZ TO SAVE LIVES & PROTECT PEOPLE'S HEALTH BY INCREASING EQUITABLE AND SUSTAINABLE USE OF VACCINES. 42 42 20 56 0 0 2270153588 2010626442 0 0 351162977 367672160 8894106 169118682 2630210671 2547417284 3524403694 2912788961 0 0 85323553 101701752 0 0 36654264 99872542 99041430 3709599789 3113532143 -1079389118 -566114859 10301246567 9505640020 2805930145 2398212512 7495316422 7107427508 X TO SAVE LIVES AND PROTECT PEOPLE'S HEALTH BY INCREASING EQUITABLE AND SUSTAINABLE USE OF VACCINES. 0 1 3021136527 2912788961 THE VACCINE GOAL: INTRODUCE AND SCALE UP VACCINESIN 2024, LOWER-INCOME COUNTRIES PROTECTED MORE PEOPLE, AGAINST MORE DISEASES, THAN ANY YEAR IN HISTORY.- 58 GAVI-SUPPORTED VACCINE INTRODUCTIONS AND PREVENTIVE CAMPAIGNS TOOK PLACE IN 2024 IN ADDITION TO 50 OUTBREAK RESPONSE VACCINATION CAMPAIGNS SUPPORTED BY GAVI.- 32.6 MILLION GIRLS FULLY IMMUNIZED AGAINST HPV WITH GAVI SUPPORT IN 2024 ALONE MORE THAN THE PREVIOUS TEN YEARS COMBINED.- 17 COUNTRIES ACCESSED CHOLERA, MENINGOCOCCAL AND YELLOW FEVER VACCINES THROUGH GAVI-SUPPORTED EMERGENCY STOCKPILES A TOTAL OF 44 TIMES IN 2024.- 57 GAVI-SUPPORTED COUNTRIES INCREASED BREADTH OF PROTECTION WITH VACCINES IN THE GAVI PORTFOLIO TO 63%, UP 8 PERCENTAGE POINTS FROM 2023.THE EQUITY GOAL: STRENGTHEN HEALTH SYSTEMS TO INCREASE EQUITY IN IMMUNIZATIONIN GAVI 5.0/5.1, HEALTH SYSTEM STRENGTHENING (HSS) SUPPORT PRIORITIZES EQUITY IN IMMUNISATION DELIVERY, TO REDUCE THE NUMBER OF ZERO-DOSE AND UNDER-IMMUNIZED CHILDREN.- >72 MILLION CHILDREN WERE REACHED WITH GAVI-SUPPORTED ROUTINE VACCINES IN 2024 MORE THAN IN ANY YEAR PREVIOUSLY.- 48 COUNTRIES HAVE INSTALLED MORE THAN 64,000 COLD CHAIN EQUIPMENT (CCE) UNITS PROCURED BY UNICEF SUPPLY DIVISION THROUGH GAVI'S COLD CHAIN EQUIPMENT OPTIMIZATION PLATFORM (CCEOP) NEARLY 2,700 IN 2024 ALONE.- AVERAGE COVERAGE OF DTP3 IN 26 LOW-INCOME COUNTRIES SUPPORTED BY GAVI IS NOT YET BACK TO PRE-PANDEMIC LEVELS (I.E. 75% IN 2019) WHILE LOWER-INCOME COUNTRIES EXCEEDED 2019 COVERAGE BY 1 PP, REACHING 87% IN 2024.- IN 2024, GAVI-SUPPORTED COUNTRIES INCREASED DTP3 COVERAGE AT 82% (COMPARED TO THE 85% GLOBAL AVERAGE).THE SUSTAINABILITY GOAL: IMPROVE SUSTAINABILITY OF IMMUNIZATION PROGRAMS2024 WAS ANOTHER RECORD-BREAKING YEAR FOR CO-FINANCING: EVEN COUNTRIES FACING SIGNIFICANT CHALLENGES INCREASED THEIR COMMITMENT TO IMMUNIZATION.- US $255 MILLION WAS CONTRIBUTED BY COUNTRIES TOWARDS THE CO-FINANCING OF GAVI-SUPPORTED VACCINES IN 2024 THE HIGHEST AMOUNT YET AND A TESTAMENT TO COUNTRY OWNERSHIP AND THE LONG-TERM FINANCIAL SUSTAINABILITY OF GAVI-SUPPORTED VACCINES.- 55 VACCINE PROGRAMS ORIGINALLY INTRODUCED WITH GAVI FUNDING ARE NOW SELF-FINANCED BY COUNTRIES AS OF 2023, UP FROM 40 IN 2018.- 100% OF COUNTRIES FULLY MET THEIR 2024 CO-FINANCING OBLIGATION EXCEPT SIX WAIVERS FOR HUMANITARIAN CRISIS.- IN THE FACE OF FISCAL CHALLENGES, CLIMATE CHANGE, CONFLICT AND INSTABILITY, MOST GAVI-SUPPORTED COUNTRIES MAINTAINED OR INCREASED DOMESTIC RESOURCES FOR CO-FINANCING OF GAVI-SUPPORTED VACCINES IN 2024, BRINGING TO US $1.9 BILLION THEIR TOTAL CONTRIBUTION SINCE THE INTRODUCTION OF THE CO-FINANCING POLICY IN 2008.THE HEALTHY MARKETS GOAL: ENSURE HEALTHY MARKETS FOR VACCINES AND RELATED PRODUCTSGAVI'S MARKET SHAPING EFFORTS MAKE LIFE-SAVING VACCINES AND OTHER IMMUNISATION PRODUCTS MORE ACCESSIBLE AND AFFORDABLE FOR LOWER-INCOME COUNTRIES.- 10 MARKETS FOR VACCINES AND IMMUNISATION PRODUCTS EXHIBITED ACCEPTABLE LEVELS OF HEALTHY MARKET DYNAMICS IN 2024, MEETING THE TARGET FOR THE YEAR.- 12 INNOVATIVE PRODUCTS WERE WITHIN THE PIPELINE OF COMMERCIAL-SCALE MANUFACTURERS IN 2024, CONTINUING TO EXCEED THE ALLIANCE TARGET OF 8 BY 2025 WELL AHEAD OF SCHEDULE.- 500,000 MPOX VACCINE DOSES WITHIN A MONTH OF THE WHO EMERGENCY DECLARATION.- THROUGH GAVI'S MARKET SHAPING EFFORTS, THE NUMBER OF MANUFACTURERS SUPPLYING PREQUALIFIED GAVI-SUPPORTED VACCINES REMAINED AT 20 IN 2024 (WITH MORE THAN HALF BASED IN LOW- AND MIDDLE-INCOME COUNTRIES) COMPARED WITH 5 IN 2001.FURTHER INFORMATION ON GAVI'S PROGRESS TOWARDS ACHIEVING ITS STRATEGIC GOALS CAN BE FOUND IN ITS 2024 ANNUAL PROGRESS REPORT, ONLINE AT: HTTPS://WWW.GAVI.ORG/PROGRAMMES-IMPACT/OUR-IMPACT/PROGRESS-REPORTS. 3021136527 1 1 0 1 0 0 0 0 0 0 1 1 0 0 1 1 0 1 0 1 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 0 0 1 X 59 0 1 20 1 0 1 SZ NO EI LU 0 0 0 0 0 0 0 0 0 0 X 42 42 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 X FRANCOIS NOTE 2024781050 40 CHEMIN DU POMMIER GRANDSACONNEX GENEVA SZ 1218 X JOSE MANUEL BARROSO CHAIR 3.00 0.00 X 0 0 0 OMAR ABDI VICE CHAIR - AS OF 01/24 3.00 0.00 X 0 0 0 KWAKU AGYEMAN-MANU BOARD MEMBER - UNTIL 10/24 3.00 0.00 X 0 0 0 TAKESHI AKAHORI BOARD MEMBER - UNTIL 07/24 3.00 0.00 X 0 0 0 BETH ARTHY BOARD MEMBER - UNTIL 08/24 3.00 0.00 X 0 0 0 ANAHIT AVANYESAN BOARD MEMBER - UNTIL 12/24 3.00 0.00 X 0 0 0 BRUCE AYLWARD BOARD MEMBER 3.00 0.00 X 0 0 0 KARIN BERLIN BOARD MEMBER - AS OF 01/24 3.00 0.00 X 0 0 0 AWA MARIE COLL SECK BOARD MEMBER 3.00 0.00 X 0 0 0 MEKDES DABA BOARD MEMBER - AS OF 04/24 3.00 0.00 X 0 0 0 JEREMIE FORRAT-JAIME BOARD MEMBER - UNTIL 09/24 3.00 0.00 X 0 0 0 ATUL GAWANDE BOARD MEMBER - AS OF 01/24 3.00 0.00 X 0 0 0 MOHAMED JAMA BOARD MEMBER - AS OF 01/24 3.00 0.00 X 0 0 0 ROBERT LUCIEN KARGOUGOU BOARD MEMBER 3.00 0.00 X 0 0 0 NAGUIB KHERAJ BOARD MEMBER - UNTIL 07/24 3.00 0.00 X 0 0 0 RUTH LAWSON BOARD MEMBER - AS OF 08/24 3.00 0.00 X 0 0 0 BVUDZAI MAGADZIRE BOARD MEMBER - AS OF 01/24 3.00 0.00 X 0 0 0 VIOLAINE MITCHELL BOARD MEMBER 3.00 0.00 X 0 0 0 KAZUHIKO NAKAMURA BOARD MEMBER - AS OF 09/24 3.00 0.00 X 0 0 0 SAAD OMER BOARD MEMBER 3.00 0.00 X 0 0 0 ANDREW DREW OTOO BOARD MEMBER 3.00 0.00 X 0 0 0 CLARISSE PAOLINI BOARD MEMBER -FROM 09/24-12/24 3.00 0.00 X 0 0 0 SAI PRASAD BOARD MEMBER 3.00 0.00 X 0 0 0 MPHU RAMATLAPENG BOARD MEMBER - UNTIL 06/24 3.00 0.00 X 0 0 0 TERESA RESSEL BOARD MEMBER - UNTIL 12/24 3.00 0.00 X 0 0 0 BUDI GUNADI SADIKIN BOARD MEMBER - AS OF 01/24 3.00 0.00 X 0 0 0 DEENA SHIFF BOARD MEMBER 3.00 0.00 X 0 0 0 ANNE SHUCHAT BOARD MEMBER 3.00 0.00 X 0 0 0 DAVID SIDWELL BOARD MEMBER - AS OF 08/24 3.00 0.00 X 0 0 0 KAREN SORENSEN BOARD MEMBER - AS OF 06/24 3.00 0.00 X 0 0 0 LIA TADESSE BOARD MEMBER - UNTIL 04/24 3.00 0.00 X 0 0 0 JUAN PABLO URIBE BOARD MEMBER 3.00 0.00 X 0 0 0 YIBING WU BOARD MEMBER 3.00 0.00 X 0 0 0 SOLEH AYUBI ALT. BOARD MEMBER 3.00 0.00 X 0 0 0 JOAN BENSON ALT. BOARD MEMBER 3.00 0.00 X 0 0 0 BERNARD OKOE BOYE ALT. BOARD MEMBER - AS OF 10/24 3.00 0.00 X 0 0 0 FRODE FORLAND ALT. BOARD MEMBER - AS OF 12/24 3.00 0.00 X 0 0 0 MELLISSA HISKO ALT. BOARD MEMBER 3.00 0.00 X 0 0 0 NADEEM JAN ALT. BOARD MEM. -FROM 01/24-07/24 3.00 0.00 X 0 0 0 GEORGE LARYEA-ADJEI ALT. BOARD MEMBER - AS OF 01/24 3.00 0.00 X 0 0 0 SILVIA LUTUCUTA ALT. BOARD MEMBER 3.00 0.00 X 0 0 0 NADEEM MAHBUB ALT. BOARD MEM. - AS OF 07/24 3.00 0.00 X 0 0 0 FRANCESCA MANNO ALT. BOARD MEMBER 3.00 0.00 X 0 0 0 BRIAN ERAZO MUNOZ ALT. BOARD MEMBER - AS OF 12/24 3.00 0.00 X 0 0 0 KATE O'BRIEN ALT. BOARD MEMBER 3.00 0.00 X 0 0 0 KRISTINE HUSOY ONARHEIM ALT. BOARD MEM. -FROM 01/24-11/24 3.00 0.00 X 0 0 0 LEILA GHARAGOZLOO PAKKALA ALT. BOARD MEMBER 3.00 0.00 X 0 0 0 MICHAEL KENT RANSON ALT. BOARD MEMBER 3.00 0.00 X 0 0 0 EDUARDO HUMBERTO RETES ALT. BOARD MEMBER - UNTIL 06/24 3.00 0.00 X 0 0 0 ALEXANDRA RUDOLPH-SEEMANN ALT. BOARD MEMBER - AS OF 01/24 3.00 0.00 X 0 0 0 LUCAS DE TOCA ALT. BOARD MEMBER - AS OF 01/24 3.00 0.00 X 0 0 0 ONEI UETELA ALT. BOARD MEMBER - AS OF 01/24 3.00 0.00 X 0 0 0 LYONPO TANDIN WANGCHUCK ALT. BOARD MEMBER - AS OF 05/24 3.00 0.00 X 0 0 0 DECHEM WANGMO ALT. BOARD MEM. -FROM 01/24-05/24 3.00 0.00 X 0 0 0 RHODA WANYENZE ALT. BOARD MEMBER 3.00 0.00 X 0 0 0 GREG WIDMYER ALT. BOARD MEMBER 3.00 0.00 X 0 0 0 DAVID MARLOW COO & ACTING CFO - UNTIL 06/24 38.00 2.00 X 785820 0 84025 DR SANIA NISHTAR CEO - AS OF 03/24 38.00 2.00 X 378553 0 77896 ASSIETOU DIOUF CHIEF FIN. OFFICER - UNTIL 04/24 39.00 1.00 X 417970 0 21532 BRENDA KILLEN DIRECTOR, GOVERNANCE 34.00 6.00 X 223961 0 67641 FRANCOIS NOTE CHIEF FIN. OFF. - AS OF 06/24 38.50 1.50 X 148298 0 47443 MARIE-ANGE SARAKA-YAO CHIEF RES. MOB. AND GROWTH OFF. 40.00 0.00 X 329569 0 71576 PASCAL BAROLLIER CHIEF ENG. AND INFORMATION 40.00 0.00 X 293386 0 82920 THABANI MAPHOSA CHIEF COUNTRY DELIVERY 40.00 0.00 X 264770 0 78231 DERRICK SIM ACT. CH. VACC. PRGM. & MKT. OFF. 40.00 0.00 X 245056 0 70750 AURELIA NGUYEN CHIEF PRGRM. OFF. - UNTIL 09/24 40.00 0.00 X 252536 0 57344 ROSEMARY OWINO - SR MNGR FIN. MGMT SPEC. - UNTIL 12/24 40.00 0.00 X 398226 0 47841 ANDREW MENDS DIRECTOR OPERATIONS & PROCUREMENT 40.00 0.00 X 311164 0 73245 ALEX DE JONQUIERES DIR., HEALTH SYS. & IMM. STRNG. 40.00 0.00 X 311268 0 69301 EDMUND GROVE DIRECTOR PROGRAMME AUDIT 40.00 0.00 X 305955 0 67278 CHARLES WHETHAM DIR., GRANT MGMT. TRANSFORMATION 40.00 0.00 X 293712 0 62923 4960244 0 979946 456 0 1 0 TECH MAHINDRA LIMITED OFF KAVE ROAD PUNE IN 411004 IT SERVICES 9536741 HELVETIC PAYROLL SA RUE DU LAUSANNE 44 GENEVA SZ 1201 TEMPORARY STAFFING, (SALARY HOSTING) 4947528 MCKINSEY AND COMPANY INC BLEICHERWEG 30 ZURICH SZ 8002 CONSULTING SERVICES 3772696 NTT DATA SPAIN SL MADRID 1 RUE PR-DE-LA-BICHETTE GENEVA SZ 1202 CONSULTING SERVICES 1885505 LINKLATERS LLP ONE SILK STREET LONDON UK EC2Y 8HQ LEGAL SERVICES 1559523 206 365836386 1621557263 23232793 2320380 2010626442 344129080 344129080 210479790 19006 186955716 0 23524074 19006 23543080 23543080 FC TRANSLATION ADJ. 900099 169116375 169116375 OTHER REVENUE 900099 2307 2307 169118682 2547417284 0 0 536790842 151169405 151169405 2761619556 2761619556 3999278 2442360 1010220 546698 67377749 41147546 17021052 9209151 13120458 8012655 3314503 1793300 15615440 9536339 3944779 2134322 1588827 970296 401370 217161 1333393 1333393 922839 922839 228000 228000 4367479 4367479 56911340 26612525 15021378 15277437 911681 260817 9506 641358 9418879 6018108 1950843 1449928 5132714 3322158 1064133 746423 3019682 1929399 625438 464845 8423204 5546767 1168310 1708127 5164755 1443839 1506004 2214912 890005 568661 184338 137006 473828 302748 98140 72940 TRAINING & RECRUITMENT 1795893 1795893 REGISTERED CHARITY FEES 39367 39367 MAINTENANCE & REPAIR 8371 5348 1734 1289 3113532143 3021136527 55741352 36654264 X 44081947 28995945 8506153 6579849 14300731 55861227 6808004210 6775243939 1506164534 738930668 154105390 81025477 8911996 6390908 1455031 2521088 1301455921 1404524550 515760750 447533071 10301246567 9505640020 230456601 40534829 463446843 463074247 1067371453 949151984 1044655248 945451452 2805930145 2398212512 X 1761702186 2864282982 5733614236 4243144526 7495316422 7107427508 10301246567 9505640020 X -566114859 91054867 87171078 X 0 1 X 1 0 X 2433703395 16367570660 4419094530 2270153588 2010626442 27501148615 2433703395 16367570660 4419094530 2270153588 2010626442 27501148615 3612515981 23888632634 16200090 11257940 93043467 349559545 344129080 814190122 27180 186856 6746 5029373 2307 5252462 28320591199 0.84350 0.84910 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2020 AMOUNT: $ 27,180. 2021 AMOUNT: $ 186,856. 2022 AMOUNT: $ 6. 2023 AMOUNT: $ 5,029,373. 2024 AMOUNT: $ 2,307. TAX REFUND - 2022 AMOUNT: $ 6,740. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 1 228000 0 0 228000 0 PART II-B, LINE 1: FEES WERE PAID FOR: 1. PRESENTATION AND OUTREACH TO MEMBERS OF THE CONGRESS AND STAFF OF THE HOUSE AND SENATE COMMITTEES ON APPROPRIATIONS, AND ANY OTHER COMMITTEES NEEDED, TO REQUEST SUPPORT FOR THE GAVI ALLIANCE; AND 2. SUPPORT AND GUIDANCE TO GAVI ALLIANCE IN POSITIONING THE ORGANIZATION WITH THE ADMINISTRATION, AND OUTREACH TO MEMBERS OF THE CONGRESS AND STAFF ON VARIOUS COMMITTEES. 1680940 113190 1567750 1601604 1122049 479555 5629452 5155669 473783 2521088 LIMITED LIABILITY COMPANIES AND LIMITED PARTNERSHIPS 590608108 F REGISTERED INVESTMENT COMPANIES 813916442 F 1404524550 PROCUREMENT ACCOUNTS PAYABLE 721177380 PAYABLE ON COVAX FACILITY ARRANGEMENTS 205156870 REFUNDABLE ADVANCE 4462895 OPERATING LEASE OBLIGATION 11391513 FOREIGN CURRENCY FORWARD CONTRACTS PAYABLE 3262794 945451452 X PART X, LINE 2: GAVI IS EXEMPT FROM INCOME TAXES IN EACH OF THE JURISDICTIONS IN WHICH IT HAS OPERATIONS. US GAAP REQUIRES THAT FINANCIAL STATEMENTS REFLECT THE EXPECTED FUTURE TAX CONSEQUENCES OF UNCERTAIN TAX POSITIONS THAT AN ENTITY HAS TAKEN OR EXPECTS TO TAKE ON A TAX RETURN, PRESUMING THE TAX AUTHORITIES' FULL KNOWLEDGE OF THE POSITION AND ALL RELEVANT FACTS. US GAAP ALSO REQUIRES THAT AN ENTITY RECOGNISES THE BENEFIT OF TAX POSITIONS WHEN IT IS MORE LIKELY THAN NOT THAT THE PROVISION WILL BE SUSTAINABLE BASED ON THE MERITS OF THE POSITION. GAVI PERFORMED AN EVALUATION OF UNCERTAIN TAX POSITIONS FOR THE YEARS ENDED 31 DECEMBER 2024 AND 2023 AND DETERMINED THAT THERE WERE NO MATTERS THAT WOULD REQUIRE RECOGNITION IN THE FINANCIAL STATEMENTS OR WHICH MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS. AS OF 31 DECEMBER 2024, THE STATUTES OF LIMITATIONS FOR TAX YEARS 2021 THROUGH 2023 REMAIN OPEN WITH THE UNITED STATES FEDERAL JURISDICTION OR THE VARIOUS STATES AND LOCAL JURISDICTIONS IN WHICH GAVI FILES TAX RETURNS. IT IS GAVI'S POLICY TO RECOGNISE INTEREST OR PENALTIES RELATED TO UNCERTAIN TAX POSITIONS, IF ANY, IN INCOME TAX EXPENSE. AS OF 31 DECEMBER 2024 AND 2023, GAVI HAD NO ACCRUED INTEREST OR PENALTIES. 1 CENTRAL AMERICA AND THE CARIBBEAN 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 24470965 EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 111040955 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 173292607 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 INVESTMENTS 7212822563 EUROPE (INCLUDING ICELAND & GREENLAND) 1 473 PROGRAM SERVICES COUNTRY PROGRAMMES MGMT. & OVERSIGHT, POLICY & PERFORMANCE, AND OPERATIONS 108347566 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 FUNDRAISING 36654264 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 92237274 RUSSIA AND THE NEWLY INDEPENDENT STATES 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 20335535 SOUTH AFRICA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 24684 SOUTH AMERICA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 10878709 SOUTH ASIA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 497903353 SUB-SAHARAN AFRICA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 1592076316 VARIOUS REGIONS 0 0 GRANTS TO RECIPIENTS LOCATED IN VARIOUS REGIONS 239359158 1 473 0 0 1 473 7779201729 2340242220 10119443949 EAST ASIA AND THE PACIFIC WORK PLAN 8533233 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 10000 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH ASIA COUNTRY PROGRAMMES 25128959 BOARD APPROVAL/WIRE TRANSFER 45209222 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 709164 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 958316 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 988762 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 1103235 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 632187 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 4258272 BOARD APPROVAL/WIRE TRANSFER 2879188 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 149136 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 98873 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH ASIA COUNTRY PROGRAMMES 137108 BOARD APPROVAL/WIRE TRANSFER 128075400 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 6091961 BOARD APPROVAL/WIRE TRANSFER 18971443 VACCINE SUPPORT FMV SOUTH ASIA COUNTRY PROGRAMMES 0 616663 VACCINE SUPPORT FMV SOUTH AMERICA COUNTRY PROGRAMMES 2417343 BOARD APPROVAL/WIRE TRANSFER 8121845 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 14506052 BOARD APPROVAL/WIRE TRANSFER 43273218 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 7529763 BOARD APPROVAL/WIRE TRANSFER 19153437 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 4307945 BOARD APPROVAL/WIRE TRANSFER 7599077 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 11891920 BOARD APPROVAL/WIRE TRANSFER 28547680 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 1019492 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 7745143 BOARD APPROVAL/WIRE TRANSFER 9306067 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 65254 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 12361205 BOARD APPROVAL/WIRE TRANSFER 23071686 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 1004642 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 307917 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 995604 BOARD APPROVAL/WIRE TRANSFER 3162722 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 33368292 BOARD APPROVAL/WIRE TRANSFER 62714290 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 3381449 BOARD APPROVAL/WIRE TRANSFER 130805 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 2231665 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 6553002 BOARD APPROVAL/WIRE TRANSFER 47565178 VACCINE SUPPORT FMV VARIOUS REGIONS COUNTRY PROGRAMMES 77870255 BOARD APPROVAL/WIRE TRANSFER 161488903 VACCINE SUPPORT FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 865018 BOARD APPROVAL/WIRE TRANSFER 0 FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 0 416049 VACCINE SUPPORT FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 3631671 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 170574 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 2487324 BOARD APPROVAL/WIRE TRANSFER 577540 VACCINE SUPPORT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 0 24980 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 463986 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 175357 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 14804 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 135099 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH AMERICA WORK PLAN 83457 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 127919 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 2709766 BOARD APPROVAL/WIRE TRANSFER 742935 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 0 197750 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 41725986 BOARD APPROVAL/WIRE TRANSFER 120291444 VACCINE SUPPORT FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 157058 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 145168 BOARD APPROVAL/WIRE TRANSFER 0 FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 86580 VACCINE SUPPORT FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 2407367 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 1430450 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 3278124 BOARD APPROVAL/WIRE TRANSFER 5015564 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC WORK PLAN 1105992 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 313220 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 12314718 BOARD APPROVAL/WIRE TRANSFER 25922362 VACCINE SUPPORT FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 679634 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 2473126 BOARD APPROVAL/WIRE TRANSFER 0 FMV MIDDLE EAST AND NORTH AFRICA WORK PLAN 566043 BOARD APPROVAL/WIRE TRANSFER 0 FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 0 70069 VACCINE SUPPORT FMV SOUTH ASIA WORK PLAN 72780 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH ASIA WORK PLAN 2667968 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 10039763 BOARD APPROVAL/WIRE TRANSFER 18076795 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 3440399 BOARD APPROVAL/WIRE TRANSFER 7009998 VACCINE SUPPORT FMV SOUTH AMERICA COUNTRY PROGRAMMES 0 122193 VACCINE SUPPORT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 7209526 BOARD APPROVAL/WIRE TRANSFER 7313746 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 26510 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 60537 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 321000 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 63832 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 144854 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 144972 BOARD APPROVAL/WIRE TRANSFER 0 FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 0 8877156 VACCINE SUPPORT FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 2074514 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 33320 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH ASIA COUNTRY PROGRAMMES 16162038 BOARD APPROVAL/WIRE TRANSFER 0 FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 3492149 BOARD APPROVAL/WIRE TRANSFER 17609594 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 549043 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 205174 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 12553 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 219812 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH ASIA WORK PLAN 661213 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 333675 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 592144 BOARD APPROVAL/WIRE TRANSFER 0 FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 0 2479040 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC WORK PLAN 212047 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 107074 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 57920 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 65491 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 8994997 BOARD APPROVAL/WIRE TRANSFER 50174045 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 266348 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 2797617 BOARD APPROVAL/WIRE TRANSFER 1081288 VACCINE SUPPORT FMV EUROPE (INCLUDING ICELAND AND GREENLAND) COUNTRY PROGRAMMES 0 1216204 VACCINE SUPPORT FMV RUSSIA AND THE NEWLY INDEPENDENT STATES COUNTRY PROGRAMMES 831713 BOARD APPROVAL/WIRE TRANSFER 2249650 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 3011333 BOARD APPROVAL/WIRE TRANSFER 5064880 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 2549751 BOARD APPROVAL/WIRE TRANSFER 1591849 VACCINE SUPPORT FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 430000 BOARD APPROVAL/WIRE TRANSFER 4061683 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 2513029 BOARD APPROVAL/WIRE TRANSFER 6303752 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 9153 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 12560784 BOARD APPROVAL/WIRE TRANSFER 29273913 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 11552770 BOARD APPROVAL/WIRE TRANSFER 24991875 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 57570 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 17025270 BOARD APPROVAL/WIRE TRANSFER 24575953 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 1145374 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 4662891 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) COUNTRY PROGRAMMES 0 135209 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 4039958 BOARD APPROVAL/WIRE TRANSFER 3712635 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 78171 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 68711 BOARD APPROVAL/WIRE TRANSFER 0 FMV RUSSIA AND THE NEWLY INDEPENDENT STATES COUNTRY PROGRAMMES 0 117697 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 122441 VACCINE SUPPORT FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 338301 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 18318946 BOARD APPROVAL/WIRE TRANSFER 62091974 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 158361 BOARD APPROVAL/WIRE TRANSFER 40571084 VACCINE SUPPORT FMV SOUTH ASIA COUNTRY PROGRAMMES 4747311 BOARD APPROVAL/WIRE TRANSFER 28468335 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 75671 BOARD APPROVAL/WIRE TRANSFER 0 FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 10028 BOARD APPROVAL/WIRE TRANSFER 399627 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 17401790 BOARD APPROVAL/WIRE TRANSFER 52180611 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 33464500 BOARD APPROVAL/WIRE TRANSFER 98277851 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 398543 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 121412 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 140400 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 349701 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 158643 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 1673638 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH ASIA COUNTRY PROGRAMMES 48606476 BOARD APPROVAL/WIRE TRANSFER 195224219 VACCINE SUPPORT FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 5126171 BOARD APPROVAL/WIRE TRANSFER 3571160 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 5432261 BOARD APPROVAL/WIRE TRANSFER 518101 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 194783 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH ASIA WORK PLAN 871517 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 107318 BOARD APPROVAL/WIRE TRANSFER 0 FMV EAST ASIA AND THE PACIFIC WORK PLAN 359006 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH AMERICA WORK PLAN 133871 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 415676 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 226309 BOARD APPROVAL/WIRE TRANSFER 8198064 VACCINE SUPPORT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 0 99844 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 26501 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 677621 BOARD APPROVAL/WIRE TRANSFER 73589 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 43868 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 922991 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 251460 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 9339537 BOARD APPROVAL/WIRE TRANSFER 12111658 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 12889644 BOARD APPROVAL/WIRE TRANSFER 13223810 VACCINE SUPPORT FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 1012507 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 80070 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 724249 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 573797 BOARD APPROVAL/WIRE TRANSFER 626810 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 17333431 BOARD APPROVAL/WIRE TRANSFER 44697830 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 4751148 VACCINE SUPPORT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 0 49940 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 22030026 BOARD APPROVAL/WIRE TRANSFER 21378594 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 23177300 BOARD APPROVAL/WIRE TRANSFER 74521085 VACCINE SUPPORT FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 209496 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 1483744 BOARD APPROVAL/WIRE TRANSFER 0 FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 21366052 BOARD APPROVAL/WIRE TRANSFER 10433809 VACCINE SUPPORT FMV RUSSIA AND THE NEWLY INDEPENDENT STATES COUNTRY PROGRAMMES 1642392 BOARD APPROVAL/WIRE TRANSFER 5129903 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 7642854 BOARD APPROVAL/WIRE TRANSFER 44826605 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA WORK PLAN 1006285 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH ASIA WORK PLAN 1054144 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 210319 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA WORK PLAN 47123 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 352526 BOARD APPROVAL/WIRE TRANSFER 0 FMV EAST ASIA AND THE PACIFIC WORK PLAN 36503 BOARD APPROVAL/WIRE TRANSFER 0 FMV EAST ASIA AND THE PACIFIC WORK PLAN 72927 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 2000000 BOARD APPROVAL/WIRE TRANSFER 0 FMV EAST ASIA AND THE PACIFIC WORK PLAN 620712 BOARD APPROVAL/WIRE TRANSFER 0 FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 400978 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 5800629 BOARD APPROVAL/WIRE TRANSFER 11400988 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 0 67640 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 338287 BOARD APPROVAL/WIRE TRANSFER 187342 VACCINE SUPPORT FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 156000 BOARD APPROVAL/WIRE TRANSFER 0 FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 18446038 BOARD APPROVAL/WIRE TRANSFER 54670307 VACCINE SUPPORT FMV EUROPE (INCLUDING ICELAND AND GREENLAND) COUNTRY PROGRAMMES 0 8084385 VACCINE SUPPORT FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 33050000 BOARD APPROVAL/WIRE TRANSFER 0 FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 3843200 BOARD APPROVAL/WIRE TRANSFER 0 FMV SOUTH AFRICA WORK PLAN 24684 BOARD APPROVAL/WIRE TRANSFER 0 FMV RUSSIA AND THE NEWLY INDEPENDENT STATES COUNTRY PROGRAMMES 265304 BOARD APPROVAL/WIRE TRANSFER 10098876 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 10593 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 2305927 BOARD APPROVAL/WIRE TRANSFER 5853492 VACCINE SUPPORT FMV EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 99119128 BOARD APPROVAL/WIRE TRANSFER 0 FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 10645870 BOARD APPROVAL/WIRE TRANSFER 33557446 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 12354803 BOARD APPROVAL/WIRE TRANSFER 32726750 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 864288 BOARD APPROVAL/WIRE TRANSFER 15280369 VACCINE SUPPORT FMV SOUTH ASIA WORK PLAN 200000 BOARD APPROVAL/WIRE TRANSFER 0 FMV 29 157 1 0 0 1 1 1 PART I, LINE 2: GAVI MONITORS THE USE OF GRANT SUPPORT AND PROTECTS AGAINST CORRUPTION AND FRAUD THROUGH COLLABORATION WITH PARTNERS, THROUGH THE MAINTENANCE AND IMPLEMENTATION OF ROBUST POLICIES AND PROCEDURES, GRANT TERMS AND CONDITIONS, AND AN AUDIT AND INVESTIGATIONS FUNCTION. POLICIES AND PROCEDURES: ALL APPLICATIONS FOR NEW SUPPORT, AND REQUESTS FOR CONTINUED SUPPORT, REQUIRE AN ENDORSEMENT AND SIGNATURES FROM A NATIONAL COORDINATION BODY WHICH IN THE CASE OF NEW VACCINES SUPPORT, IS THE INTER-AGENCY COORDINATION COMMITTEE (ICC). THE ICC INCLUDES ON ITS MEMBERSHIP, IN ADDITION TO HIGH LEVEL REPRESENTATION OF THE GOVERNMENT OF GAVI COUNTRIES, GAVI PARTNERS SUCH AS THE WORLD HEALTH ORGANIZATION, UNICEF, NON-GOVERNMENTAL ORGANIZATIONS AND DONOR GOVERNMENTS. IN THE CASE OF CASH SUPPORT FOR HEALTH SYSTEM STRENGTHENING, ENDORSEMENT IS REQUIRED FROM THE HEALTH SECTOR COORDINATION COMMITTEE (HSCC) OR OTHER SIMILAR INTER-AGENCY COMMITTEE WHICH ALSO INCLUDES THE GOVERNMENT, BILATERAL, MULTILATERAL AGENCIES AND CIVIL SOCIETY REPRESENTATIVES. - IN ADDITION, THE APPLICATIONS SUBMITTED MUST INCLUDE THE SIGNATURES OF THE MINISTER OF HEALTH AND THE MINISTER OF FINANCE. THE GAVI NEW APPLICATIONS GUIDELINES PROVIDE DETAILS ON GAVI SUPPORT, INCLUDING GENERAL PRINCIPLES AND THE PROCESS FOR APPLYING AND MONITORING ACTIVITIES. A PARTNERSHIP FRAMEWORK AGREEMENT IS ENTERED INTO BETWEEN GAVI AND COUNTRIES THAT SETS OUT THE TERMS AND CONDITIONS GOVERNING GAVI SUPPORT. THE MAIN TOOLS/APPROACHES USED BY GAVI TO MONITOR THE USE OF GAVI SUPPORT ARE THE FOLLOWING: - (1) IN-COUNTRY COORDINATING AND/OR SIMILAR SUPERVISORY COMMITTEES (ICC AND HSCC) AND RELATED TECHNICAL WORKING GROUPS; (2) ROUTINE MONITORING MISSIONS IN-COUNTRY, LED BY SENIOR COUNTRY MANAGERS, WORKING WITH PARTNERS AND IN-COUNTRY COUNTERPARTS AS WELL AS FORMAL ANNUAL JOINT APPRAISALS THAT REVIEW PERFORMANCE OF ALL GRANTS IN-COUNTRY; (3) FOR CASH GRANTS - RISK-BASED PROGRAM AUDITS BY GAVI AND ANNUAL EXTERNAL AUDITS BY THE COUNTRY IN ADDITION TO QUARTERLY/SEMIANNUAL FINANCIAL REPORTING REQUIREMENTS. THE EXTERNAL AUDITS AND FINANCIAL REPORTS ARE REVIEWED BY GAVI; (4) MONITORING REVIEWS OF GRANT MANAGEMENT REQUIREMENTS ARISING FROM THE PROGRAM CAPACITY ASSESSMENTS THAT INDEPENDENTLY ASSESSED FINANCIAL MANAGEMENT ARRANGEMENTS AND PROGRAMMATIC/MANAGEMENT CAPACITIES IN-COUNTRY AS WELL AS INVESTIGATIONS IN CASES OF SUSPECTED OR ACTUAL MISUSE OF FUNDS; (5) STRATEGIC ENGAGEMENT WITH FIRMS (APS) PROVIDING OVERSIGHT & ASSURANCE SERVICES OVER COUNTRY IMPLEMENTATION OF CASH GRANTS. THE ASSURANCE FRAMEWORK PROVIDES MANAGEMENT WITH THE CONFIDENCE THAT GAVI OBJECTIVES WOULD BE ATTAINED WITHIN GAVI'S RISK APPETITE. (6) ROUTINE REVIEW BY THE SECRETARIAT OR INDEPENDENTLY CONTRACTED PROVIDERS OF QUANTITATIVE AND QUALITATIVE INFORMATION PROVIDED THROUGH THE MONITORING AND PERFORMANCE MANAGEMENT SYSTEM AND JOINT APPRAISALS, AS WELL AS ANY ADDITIONAL REPORTS/EVALUATIONS/SURVEYS/ASSESSMENTS SUBMITTED TO GAVI BY RECIPIENT GOVERNMENTS. (7) HIGH LEVEL MISSIONS IN-COUNTRY, LED BY GAVI CHIEF EXECUTIVE OFFICER, WORKING WITH LEADERS OF ALLIANCE PARTNERS AND IN-COUNTRY COUNTERPARTS AS WELL AS USE OF ACCOUNTABILITY FRAMEWORKS THAT REVIEW IMMUNIZATION PROGRAMMING AND FINANCING COMMITMENTS. COLLABORATION WITH PARTNERS: GAVI MAINTAINS FORMAL AND INFORMAL CONTACT WITH THE PARTNERS (THE GATES FOUNDATION, UNICEF, WHO, THE WORLD BANK GROUP, CIVIL SOCIETY ORGANIZATIONS, DEVELOPING COUNTRY GOVERNMENTS, DEVELOPING COUNTRY PHARMACEUTICAL INDUSTRY, INDUSTRIALIZED COUNTRY GOVERNMENTS, INDUSTRIALIZED COUNTRY PHARMACEUTICAL INDUSTRY, RESEARCH AND TECHNICAL HEALTH INSTITUTES) AT VARIOUS LEVELS TO HELP ENSURE THAT RELEVANT INFORMATION ABOUT SUSPECTED AND ACTUAL CASES OF CORRUPTION AND MISUSE OF FUNDS IS SHARED ON A TIMELY BASIS. - GAVI ENGAGES UNICEF, A KEY PARTNER IN GAVI, THE VACCINE ALLIANCE, FOR THE PURCHASE AND DELIVERY OF VACCINES. UNICEF MANAGES VACCINE LOGISTICS AND DELIVERY IN ACCORDANCE WITH ITS INTERNAL CONTROLS AND INTERNAL AND EXTERNAL AUDITS AS MANDATED BY ITS MEMBER STATES. GAVI AND UNICEF HAVE ENTERED INTO VARIOUS AGREEMENTS WHICH PROVIDE FOR CONFIRMATIONS, ASSURANCES AND INFORMATION REGARDING UNICEF ACTIVITIES CARRIED OUT ON BEHALF OF THE ALLIANCE. AUDIT AND INVESTIGATIONS: THE PRIMARY RESPONSIBILITY OF THE AUDIT AND INVESTIGATIONS FUNCTION IS ASSISTING THE MANAGEMENT AND STAKEHOLDERS OF GAVI IN ACCOMPLISHING ITS OBJECTIVES AND TO ENHANCE AND PROTECT ORGANIZATIONAL VALUE BY PROVIDING RISK-BASED AND OBJECTIVE ASSURANCE, AND INSIGHT, AND ASSESS PROBITY. THE WORK OF AUDIT AND INVESTIGATIONS EXTENDS NOT ONLY TO THE SECRETARIAT, BUT ALSO TO GAVI-SUPPORTED PROGRAMS IN-COUNTRY INCLUDING THE FACILITY. AUDIT AND INVESTIGATIONS ARE LED BY A MANAGING DIRECTOR WHO REPORTS TO THE BOARD, THROUGH ROUTINE REPORTING TO THE AUDIT AND FINANCE COMMITTEE, AND TO THE CHIEF EXECUTIVE OFFICER. THE TRANSPARENCY AND ACCOUNTABILITY POLICY (TAP): THROUGH TAP, GAVI IS ABLE TO ENSURE THAT ALL GAVI SUPPORT AT COUNTRY LEVEL IS MANAGED IN A TRANSPARENT AND ACCOUNTABLE MANNER THROUGH SYSTEMS THAT INCLUDE APPROPRIATE OVERSIGHT MECHANISMS, AND THAT THE SUPPORT IS USED ACCORDING TO THE PROGRAM OBJECTIVES AS OUTLINED IN INDIVIDUAL COUNTRY AGREEMENTS. THE POLICY GOVERNS THE TRANSPARENCY AND ACCOUNTABILITY ASPECTS OF GAVI SUPPORT PROVIDED IN THE FORM OF CASH, VACCINES AND VACCINE DEVICES AT COUNTRY LEVEL. THE PRINCIPLES GOVERNING TAP INCLUDES; RESPECT AID EFFECTIVENESS PRINCIPLES; FOCUS ON PREVENTION; RELATE MONITORING TO RISK; PROMOTE FLEXIBILITY AND COUNTRY OWNERSHIP; PROMOTE MUTUAL ACCOUNTABILITY; AND STRENGTHEN COUNTRY SYSTEMS. TAP AIMS TO RETAIN A FLEXIBLE AND NON-PERSPECTIVE APPROACH TO ALLOW FOR DIFFERENCES IN COUNTRY CONTEXT AND ENHANCES CONTINUED EFFORTS BY GAVI TO SUPPORT SUSTAINABLE DEVELOPMENT OF COUNTRY CAPACITY. PART I, LINE 3: THE ALLIANCE REPORTED THE EXPENDITURES BASED ON THE ACCOUNTING METHOD USED IN ITS AUDITED FINANCIAL STATEMENTS WHICH IS ON AN ACCRUAL BASIS. PART I, LINE 3, COLUMN (D) RECIPIENTS REFER TO COUNTRIES OR PARTNERS LOCATED IN THE REGION. PART II, LINE 1 THE ALLIANCE REPORTED THE EXPENDITURES BASED ON THE ACCOUNTING METHOD USED IN ITS AUDITED FINANCIAL STATEMENTS WHICH IS ON AN ACCRUAL BASIS. 1 ALBERT B SABIN VACCINE INSTITUTE 2000 PENN AVENUE NW SUITE 7100 WASHINGTON DC 20006 061389829 501(C)(3) 925445 0 N/A PARTNER SUPPORT ANALYTICS HT INC 24-55 SW 93 TERRACE APT 102T MIAMI FL 33186 462397616 424312 0 N/A PARTNER SUPPORT CAMPAIGN FOR TOBACCO-FREE KIDS (THROUGH GLOBAL HEALTH ADVOCACY INCUBATOR) 1400 I STREET NW STE 1200 WASHINGTON DC 20005 521969967 501(C)(3) 2450677 0 N/A PARTNER SUPPORT CENTER FOR DISEASE CONTROL 1600 CLIFTON ROAD ATLANTA GA 30303 586051157 170(C)(1) 193500 0 N/A PARTNER SUPPORT CENTER FOR DISEASE CONTROL FOUNDATION 600 PEACHTREE ST NE SUITE 1000 ATLANTA GA 30303 582106707 501(C)(3) 4762977 0 N/A PARTNER SUPPORT CLINTON HEALTH ACCESS INITIATIVE 383 DORCHESTER AVENUE SUITE 400 BOSTON MA 02127 271414646 501(C)(3) 12569078 0 N/A PARTNER SUPPORT FAMILY HEALTH INTERNATIONAL 359 BLACKWELL STREET SUITE 200 DURHAM NC 27701 237413005 501(C)(3) 12276 0 N/A PARTNER SUPPORT GDI SOLUTIONS LLC 1401 K STREET NW SUITE 900 WASHINGTON DC 20005 881343562 501(C)(3) 1489134 0 N/A PARTNER SUPPORT HARVARD PRESIDENT AND FELLOWS OF HARVARD COLLEGE 1033 MASSACHUSSETS AVENUE CAMBRIDGE MA 02138 042103580 501(C)(3) 9688 0 N/A PARTNER SUPPORT INTEGRATE HEALTH INC 16 GRANITE STREET MEDWAY MA 02053 134288670 501(C)(3) 1487180 0 N/A PARTNER SUPPORT INTERNATIONAL ORGANIZATION FOR MIGRATION 399 PARK AVENUE NEW YORK NY 10168 521525929 501(C)(3) 346602 0 N/A PARTNER SUPPORT JOHNS HOPKINS UNIVERSITY 1101 E33RD STREET SUITE D200 BALTIMORE MD 21218 520595110 501(C)(3) 5549120 0 N/A PARTNER SUPPORT JSI RESEARCH & TRAINING INSTITUTE INC 2733 CRYSTAL DRIVE 4TH FLOOR ARLINGTON VA 22202 042679824 501(C)(3) 10024296 0 N/A PARTNER SUPPORT KATI COLLECTIVE INC 13346 108TH AVENUE SW VASHON WA 98070 843168072 294375 0 N/A PARTNER SUPPORT KHUSHI BABY INC 6016 LOUIS WAY EL DORADO HILLS CA 95762 465767894 501(C)(3) 450000 0 N/A PARTNER SUPPORT MASSACHUSETTS INSTITUTE OF TECHNOLOGY 77 MASSACHUSETTS AVENUE CAMBRIDGE MA 02139 042103594 501(C)(3) 84917 0 N/A PARTNER SUPPORT NEXLEAF ANALYTICS 1964 WESTWOOD BOULEVARD LOS ANGELES CA 90025 900514027 501(C)(3) 1623092 0 N/A PARTNER SUPPORT PAN AMERICAN SANITARY BUREAU 525 TWENTY THIRD STREET NW WASHINGTON DC 20037 521804954 170(C)(1) 1617453 0 N/A PARTNER SUPPORT PARSYL INC 2714 WALNUT STREET DENVER CO 80205 814027966 100000 0 N/A PARTNER SUPPORT PATH 2201 WESTLAKE AVENUE SEATTLE WA 98109 911157127 501(C)(3) 4785426 0 N/A PARTNER SUPPORT PHAROS GLOBAL HEALTH ADVISORS 105 MORTON STREET NEWTON MA 02459 812764710 306642 0 N/A PARTNER SUPPORT PICMA AFRICA INC 33610 SOLON ROAD 3 SOLON OH 44139 852870008 76140 0 N/A PARTNER SUPPORT POPULATION SERVICES INTERNATIONAL 1120 19TH STREET NW SUITE 600 WASHINGTON DC 20036 560942853 501(C)(3) 776054 0 N/A PARTNER SUPPORT RESEARCH TRIANGLE INSTITUTE 3040 E CORNWALLIS ROAD DURHAM NC 27709 560686338 501(C)(3) 791914 0 N/A PARTNER SUPPORT RESULTS FOR DEVELOPMENT INSTITUTE 1111 19TH STREET NW SUITE 700 WASHINGTON DC 20036 208530747 501(C)(3) 2550948 0 N/A PARTNER SUPPORT THE DIFFERENCE A2C LLC 661 AUBURN AVENUE NE SUITE 5 ATLANTA GA 30312 261133788 127106 0 N/A PARTNER SUPPORT THE ELEANOR CROOK FOUNDATION 227 N MITCHELL STREET SAN MARCOS TX 78666 742857866 501(C)(3) 750000 0 N/A PARTNER SUPPORT THE ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION 1350 I STREET NW SUITE 400 WASHINGTON DC 20005 954191698 501(C)(3) 521195 0 N/A PARTNER SUPPORT THE GEORGE WASHINGTON UNIVERSITY 45155 RESEARCH PLACE SUITE 360 ASHBURN VA 20147 530196584 501(C)(3) 65673 0 N/A PARTNER SUPPORT THE PENNSYLVANIA STATE UNIVERSITY 200 INNOVATION BLVD SUITE 110 UNIVERSITY PARK PA 16802 246000376 501(C)(3) 98913 0 N/A PARTNER SUPPORT THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK LOW MEMORIAL LIBRARY 535 W 116TH ST NEW YORK NY 10027 135598093 501(C)(3) 178605 0 N/A PARTNER SUPPORT THE WORLD BANK (IBRD) 1818 H STREET WASHINGTON DC 20033 980002549 INTERNATIONAL NGO 2778000 0 N/A PARTNER SUPPORT TRUSTEES OF BOSTON UNIVERSITY 881 COMMONWEALTH AVENUE BOSTON MA 02215 042103547 501(C)(3) 30000 0 N/A PARTNER SUPPORT UNICEF 333 EAST 38TH STREET NEW YORK NY 10116 131760110 501(C)(3) 87688260 0 N/A PARTNER SUPPORT UNIVERSITY OF WASHINGTON 1400 NE CAMPUS PARKWAY SEATTLE WA 98195 916001537 501(C)(3) 200000 0 N/A PARTNER SUPPORT VILLAGE REACH 2900 EASTLAKE AVE E SUITE 230 SEATTLE WA 98102 912083484 501(C)(3) 2441687 0 N/A PARTNER SUPPORT YALE UNIVERSITY PO BOX 1873 NEW HAVEN CT 06508 060646973 501(C)(3) 58726 0 N/A PARTNER SUPPORT ZENYSIS TECHNOLOGIES INC 2325 3RD STREET NUMBER 213 SAN FRANCISCO CA 94107 810929294 346061 0 N/A PARTNER SUPPORT ZIPLINE INTERNATIONAL INC 495 PINE AVENUE HALF MOON BAY CA 94019 453197601 2183933 0 N/A PARTNER SUPPORT 31 8 PART I, LINE 2: GAVI MONITORS THE USE OF GRANT FUNDS MADE TO ENTITIES INSIDE THE US AND SUBSEQUENTLY DISBURSED IN GAVI PROGRAM COUNTRIES AS DESCRIBED IN SCHEDULE F, PART V. ANY GRANT FUNDS MADE TO ENTITIES INSIDE THE US AND USED INSIDE THE US ARE MONITORED THROUGH THE FOLLOWING WAYS: (I) THROUGH, AT MINIMUM, ANNUAL TECHNICAL PROGRESS REPORTS AND CERTIFIED FINANCIAL REPORTS FROM GRANTEES THAT SUPPORT THE ACHIEVEMENT OF MILESTONES STIPULATED IN THE GRANT AGREEMENTS. REPORTS ARE RECEIVED AND REVIEWED BY THE GAVI STAFF BUSINESS OWNER; AND (II) ARE SUBJECT TO GAVI INTERNAL AUDIT AS APPROPRIATE. X X 1 1 X X X 1 0 0 0 0 0 0 1 0 DAVID MARLOW COO & ACTING CFO - UNTIL 06/24 301751 0 14486 0 469583 0 65905 0 18120 0 869845 0 0 0 DR SANIA NISHTAR CEO - AS OF 03/24 291032 0 0 0 87521 0 70128 0 7768 0 456449 0 0 0 ROSEMARY OWINO - SR MNGR FIN. MGMT SPEC. - UNTIL 12/24 177129 0 0 0 221097 0 36497 0 11344 0 446067 0 0 0 ASSIETOU DIOUF CHIEF FIN. OFFICER - UNTIL 04/24 80878 0 0 0 337092 0 17751 0 3781 0 439502 0 0 0 MARIE-ANGE SARAKA-YAO CHIEF RES. MOB. AND GROWTH OFF. 292446 0 36556 0 567 0 65904 0 5672 0 401145 0 0 0 ANDREW MENDS DIRECTOR OPERATIONS & PROCUREMENT 244825 0 10913 0 55426 0 53808 0 19437 0 384409 0 0 0 ALEX DE JONQUIERES DIR., HEALTH SYS. & IMM. STRNG. 244824 0 11018 0 55426 0 53809 0 15492 0 380569 0 0 0 PASCAL BAROLLIER CHIEF ENG. AND INFORMATION 292446 0 373 0 567 0 65904 0 17016 0 376306 0 0 0 EDMUND GROVE DIRECTOR PROGRAMME AUDIT 237116 0 2367 0 66472 0 51786 0 15492 0 373233 0 0 0 CHARLES WHETHAM DIR., GRANT MGMT. TRANSFORMATION 213378 0 0 0 80334 0 45703 0 17220 0 356635 0 0 0 THABANI MAPHOSA CHIEF COUNTRY DELIVERY 264203 0 0 0 567 0 58794 0 19437 0 343001 0 0 0 DERRICK SIM ACT. CH. VACC. PRGM. & MKT. OFF. 244489 0 0 0 567 0 53734 0 17016 0 315806 0 0 0 AURELIA NGUYEN CHIEF PRGRM. OFF. - UNTIL 09/24 213811 0 36556 0 2169 0 49427 0 7917 0 309880 0 0 0 BRENDA KILLEN DIRECTOR, GOVERNANCE 223394 0 0 0 567 0 48204 0 19437 0 291602 0 0 0 FRANCOIS NOTE CHIEF FIN. OFF. - AS OF 06/24 148298 0 0 0 0 0 32796 0 14647 0 195741 0 0 0 PART I, LINE 1A UNDER AN AGREEMENT WITH THE SWISS GOVERNMENT, NON-SWISS EMPLOYEES OF THE GAVI ALLIANCE WORKING IN GENEVA, SWITZERLAND ARE EXEMPT FROM SWISS FEDERAL, CANTONAL AND COMMUNAL TAXES ON SALARIES AND ALLOWANCES PAID TO THEM BY THE GAVI ALLIANCE. AS THE GAVI ALLIANCE IN GENEVA OPERATES AN INTERNAL TAX SCHEME, EMPLOYEES OF SWISS NATIONALITY ARE ALSO EXEMPT FROM SWISS FEDERAL, CANTONAL AND COMMUNAL TAXES ON SALARIES AND ALLOWANCES PAID TO THEM BY THE GAVI ALLIANCE. TO ENSURE EQUITY AMONGST GAVI EMPLOYEES, CERTAIN ELIGIBLE EMPLOYEES WHO HAVE A FOREIGN TAX LIABILITY ON THEIR GAVI SALARY AND ALLOWANCES (E.G. US NATIONALS AND EMPLOYEES LIVING IN FRANCE) MAY RECEIVE ASSISTANCE FROM GAVI IN MEETING THEIR TAX OBLIGATIONS IN ACCORDANCE WITH GAVI'S FOREIGN TAX POLICY. PART I, LINE 4A DURING THE YEAR ENDED DECEMBER 31, 2024, SEVERANCE WAS PAID TO ASSIETOU DIOUF, CHIEF FINANCIAL OFFICER, IN THE AMOUNT OF $303,291 (CHF 267,579), TO DAVID MARLOW, COO & ACTING CFO, IN THE AMOUNT OF $131,340 (CHF 115,875), AND TO ROSEMARY OWINO, SENIOR MANAGER, FINANCIAL MANAGEMENT SPECIALIST, IN THE AMOUNT OF $188,463 (CHF 166,272). PART I, LINE 7 FOR THE YEAR ENDED DECEMBER 31, 2024, BONUS & INCENTIVE COMPENSATION FOR MARIE-ANGE SARAKA-YAO, CHIEF RESOURCE MOBILISATION AND GROWTH OFFICER, AND AURELIA NGUYEN, CHIEF PROGRAMME OFFICER, INCLUDES THE AMOUNT OF $29,245 (CHF 25,801) EACH AWARDED BY THE COO IN JUNE 2023 AS A ONE-OFF PAYMENT FOR RECOGNITION AND RETENTION PURPOSE IN THE CONTEXT OF THE LEADERSHIP TRANSITIONS IN 2024. SCHEDULE J, PART II, COLUMN (A): DAVID MARLOW WAS CHIEF OPERATING OFFICER (COO) UNTIL 06/23; INTERIM CHIEF EXECUTIVE OFFICER (CEO) UNTIL 03/24; COO & ACTING CHIEF FINANCIAL OFFICER UNTIL 06/24; AND SPECIAL ADVISOR TO THE CEO FROM 07/24-12/24. DAVID MARLOW'S ROLE AS INTERIM CHIEF FINANCIAL OFFICER WAS TRANSITIONED TO FRANCOIS NOTE DURING THE MONTH OF JUNE. SCHEDULE J, PART II, COLUMN (B)(III): OTHER REPORTABLE COMPENSATION - THIS INCLUDES ALLOWANCES DUE TO EMPLOYEES UNDER GAVI'S HR POLICY, INCLUDING ALLOWANCES FOR RELOCATION, EDUCATION GRANT AND REIMBURSEMENT OF NON-SWISS TAXES ON GAVI INCOME. GAVI'S REPORTED COMPENSATION, AS VALUED IN SWISS FRANCS (CHF) IS: A | BASE COMPENSATION B | BONUS AND INCENTIVE "OTHER REPORTED COMPENSATION" INCLUDES THE FOLLOWING: C | US TAX REIMBURSEMENT D | EDUCATION GRANT E | OTHER BENEFITS, INCLUDING SEVERANCE PAYMENTS F | RETIREMENT PLAN G | NONTAXABLE HEALTH INSURANCE DR. SETH BERKLEY 2023 | A) 256,025, B) 0, C) 108,923, D) 0, E) 92,638, F) 57,696, G) 14,663 2024 | REPORTABLE COMPENSATION NOT REQUIRED FOR THIS PERIOD. BRENDA KILLEN 2023 | A) 192,934, B) 0, C) 0, D) 24,200, E) 0, F) 41,491, G) 13,668 2024 | A) 197,090, B) 0, C) 0, D) 0, E) 500, F) 42,528, G) 17,148 ASSIETOU DIOUF 2023 | A) 214,064, B) 0, C) 0, D) 0, E) 0, F) 46,982, G) 10,008 2024 | A) 71,354, B, 0, C) 0, D) 0, E) 297,401, F) 15,661, G) 3,336 THABANI MAPHOSA 2023 | A) 216,190, B) 0, C) 0, D) 24,200, E) 0, F) 47,538, G) 17,148 2024 | A) 233,094, B) 0, C) 0, D) 0, E) 500, F) 51,871, G) 17,148 PASCAL BAROLLIER 2023 | A) 252,038, B) 0, C) 0, D) 0, E) 0, F) 56,797, G) 25,020 2024 | A) 258,012, B) 329, C) 0, D) 0, E) 500, F) 58,144, G) 15,012 MARIE-ANGE SARAKA-YAO 2023 | A) 258,011, B) 8,560, C) 0, D) 0, E) 0, F) 58,144, G) 5,004 2024 | A) 258,011, B) 32,252, C) 0, D) 0, E) 500, F) 58,144, G) 5,004 ANDREW MENDS 2023 | A) 211,895, B) 0, C) 0, D) 48,400, E) 0, F) 46,443, G) 13,668 2024 | A) 215,997, B) 9,628, C) 0, D) 48,400, E) 500, F) 47,472, G) 17,148 DAVID MARLOW 2023 | A) 263,797, B) 0, C) 137,232, D) 0, E) 0, F) 55,716, G) 16,511 2024 | A) 266,220 B) 12,780, C) 249,447, D) 0, E) 164,844, F) 58,145, G) 15,986 DERRICK SIM 2023 | A) 205,756, B) 0, C) 0, D) 0, E) 0, F) 44,417, G) 20,016 2024 | A) 215,701, B) 0, C) 0, D) 0, E) 500, F) 47,407, G) 15,012 AURELIA NGUYEN 2023 | A) 258,011, B) 3,311, C) 0, D) 0, E) 0, F) 58,144, G) 8,664 2024 | A) 193,509, B) 32,252, C) 0, D) 0, E) -2,960, F) 43,607, G) 6,985 CATHERINE PAWLOW 2023 | A) 224,326, B) 5,608, C) 0, D) 0, E) 251,614, F) 49,609, G) 10,008 2024 | REPORTABLE COMPENSATION NOT REQUIRED FOR THIS PERIOD. SUSAN MACKAY 2023 | A) 79,709, B) 0, C) 0, D) 0, E) 250,901, F) 16,378, G) 5,004 2024 | REPORTABLE COMPENSATION NOT REQUIRED FOR THIS PERIOD. ALEX DE JONQUIERES 2023 | A) 215,998, B) 3,949, C) 0, D) 48,400, E) 0, F) 47,472, G) 13,668 2024 | A) 215,997, B) 9,720, C) 0, D) 48,400, E) 500, F) 47,473, G) 13,668 EDMUND GROVE 2023 | A) 213,350, B) 0, C) 0, D) 61,542, E) 0, F) 46,762 G) 13,668 2024 | A) 209,196, B) 2,088, C) 0, D) 58,145, E) 500, F) 45,688, G) 13,668 DR. SANIA NISHTAR 2023 | REPORTABLE COMPENSATION NOT REQUIRED FOR THIS PERIOD. 2024 | A) 256,763, B) 0, C) 0, D) 0, E) 77,216, F) 61,871, G) 6,853 FRANCOIS NOTE 2023 | REPORTABLE COMPENSATION NOT REQUIRED FOR THIS PERIOD. 2024 | A) 130,836, B) 0, C) 0, D) 0, E) 0, F) 28,934, G) 12,922 ROSEMARY OWINO 2023 | REPORTABLE COMPENSATION NOT REQUIRED FOR THIS PERIOD. 2024 | A) 156,273, B) 0, C) 0, D) 0, E) 195,063, F) 32,200, G) 10,008 CHARLES WHETHAM 2023 | REPORTABLE COMPENSATION NOT REQUIRED FOR THIS PERIOD. 2024 | A) 188,253, B) 0, C) 0, D) 70,375, E) 500, F) 40,322, G) 15,192 THE CHF-USD EXCHANGE RATE IS 1.11490 IN 2023 AND 1.13346 IN 2024. ALL OF GAVI ALLIANCE'S HIGHEST COMPENSATED EMPLOYES ARE BASED IN GENEVA, SWITZERLAND. THESE EMPLOYEES' SALARIES REFLECTED THE COST OF LIVING IN GENEVA AND INCLUDE BENEFITS SUCH AS EDUCATION GRANT AND US TAX REIMBURSEMENT. THE BENEFITS PROVIDED TO EMPLOYEES ARE COMPARABLE TO THOSE PROVIDED BY OTHER INTERNATIONAL NON-FOR-PROFIT ORGANISATIONS. X 26660 2320380 FMV 0 1 0 PART I, COLUMN (B): GAVI REPORTS THE NUMBER OF DOSES IN COLUMN (B). FORM 990, BOX 5: GAVI IS AN INDEPENDENT NON-PROFIT FOUNDATION WITHIN THE MEANING OF ARTICLES 80 ET SEQ. OF THE SWISS CIVIL CODE. IT IS REGISTERED AT THE REGISTRY OF COMMERCE OF THE CANTON OF GENEVA AND PLACED UNDER THE SUPERVISION OF THE SWISS SUPERVISORY BOARD FOR FOUNDATIONS. FORM 990, PART I, LINE 1: GAVI, THE VACCINE ALLIANCE IS A PUBLIC-PRIVATE PARTNERSHIP THAT HELPS VACCINATE MORE THAN HALF THE WORLD'S CHILDREN AGAINST SOME OF THE WORLD'S DEADLIEST DISEASES. THE VACCINE ALLIANCE BRINGS TOGETHER DEVELOPING COUNTRY AND DONOR GOVERNMENTS, THE WORLD HEALTH ORGANIZATION, UNICEF, THE WORLD BANK, THE VACCINE INDUSTRY, TECHNICAL AGENCIES, CIVIL SOCIETY, THE GATES FOUNDATION AND OTHER PRIVATE SECTOR PARTNERS. SINCE ITS INCEPTION IN 2000, GAVI HAS HELPED TO IMMUNISE A WHOLE GENERATION OVER 1 BILLION CHILDREN AND PREVENTED MORE THAN 18.8 MILLION FUTURE DEATHS, HELPING TO HALVE CHILD MORTALITY IN 78 LOWER-INCOME COUNTRIES. GAVI ALSO PLAYS A KEY ROLE IN IMPROVING GLOBAL HEALTH SECURITY BY SUPPORTING HEALTH SYSTEMS AS WELL AS FUNDING GLOBAL STOCKPILES FOR EBOLA, CHOLERA, MENINGOCOCCAL AND YELLOW FEVER VACCINES. AFTER TWO DECADES OF PROGRESS, GAVI IS NOW FOCUSED ON PROTECTING THE NEXT GENERATION, ABOVE ALL THE ZERO-DOSE CHILDREN WHO HAVE NOT RECEIVED EVEN A SINGLE VACCINE SHOT. THE VACCINE ALLIANCE EMPLOYS INNOVATIVE FINANCE AND THE LATEST TECHNOLOGY FROM DRONES TO BIOMETRICS TO SAVE LIVES, PREVENT OUTBREAKS BEFORE THEY CAN SPREAD AND HELP COUNTRIES ON THE ROAD TO SELF-SUFFICIENCY. FORM 990, PART III, LINE 3 COVAX FACILITY ENDED ON DECEMBER 31, 2023, AFTER HAVING DELIVERED NEARLY 2 BILLION COVID-19 VACCINE DOSES AND SAFE INJECTION DEVICES TO 146 ECONOMIES, AND IS ESTIMATED TO HAVE AVERTED OVER 2.7 MILLION DEATHS IN AMC LOWER-INCOME PARTICIPATING ECONOMIES. THE GAVI BOARD AGREED IN DECEMBER 2023 TO CONTINUE SUPPORTING COUNTRIES IN 2024-2025 WITH COVID-19 VACCINES THROUGH THE COVID-19 VACCINE PROGRAMME WHICH WAS INTEGRATED INTO THE GAVI-CORE PROGRAMMES. FORM 990, PART I, LINE 5: PART I, LINE 5 LISTS THE TOTAL NUMBER OF EMPLOYEES BASED IN WASHINGTON, DC AND WHO RECEIVED THE FORM W-2. IT DOES NOT INCLUDE FOREIGN AND US CITIZEN EMPLOYEES BASED IN GENEVA, SWITZERLAND. THE TOTAL NUMBER OF EMPLOYEES, INCLUDING US CITIZEN EMPLOYEES BASED IN GENEVA AND WASHINGTON, DC, IS 488. FORM 990, PART VI, SECTION B, LINE 11B THE OUTSOURCED ACCOUNTANT (OA), IN COLLABORATION WITH THE SENIOR MANAGER OF FINANCIAL REPORTING (SMFR), GATHERS ALL INFORMATION NEEDED TO PREPARE THE FEDERAL FORM 990 FROM THE RESPECTIVE GAVI DEPARTMENTS. OA THEN PREPARES THE DRAFT FEDERAL FORM 990 AND PROVIDES IT TO THE SMFR AND GAVI HEAD OF FINANCIAL REPORTING, ACCOUNTING AND CONTROLLING (HFRAC) FOR REVIEW. THE HFRAC REVIEWS THE DRAFT FEDERAL FORM 990 AND DISCUSSES ANY NECESSARY CHANGES WITH THE OA AND SMFR. THE OA THEN SUBMITS THE DRAFT FEDERAL FORM 990 TO THE TAX FIRM FOR REVIEW AND DISCUSSES ANY NECESSARY UPDATES PROVIDED BY THE TAX FIRM, AFTER WHICH THE DRAFT FEDERAL FORM 990 IS UPDATED BY THE OA. THE SMFR THEN CIRCULATES THE UPDATED DRAFT FEDERAL FORM 990 TO VARIOUS GAVI TEAMS FOR THEIR REVIEW AND COMMENT. THE DRAFT FEDERAL FORM 990 IS UPDATED FOR COMMENTS RECEIVED AS DEEMED NECESSARY BY THE HFRAC. THE DRAFT FEDERAL FORM 990, INCLUDING ALL REQUIRED SCHEDULES, IS PROVIDED TO THE AUDIT AND FINANCE COMMITTEE. A GAVI AUTHORIZED REPRESENTATIVE SIGNS THE FEDERAL FORM 990 AFTER WHICH IT IS FILED WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C THE GOVERNANCE TEAM CIRCULATES THE CONFLICT OF INTEREST DISCLOSURE FORMS TO THE BOARD MEMBERS ANNUALLY. GOVERNANCE MONITORS DISCLOSURE FORMS BY COLLECTING ALL CONFLICT OF INTEREST DISCLOSURES FROM BOARD MEMBERS. THE POLICY IS MONITORED BY THE BOARD OF DIRECTORS ITSELF, AND RELEVANT CONFLICTS ARE DISCLOSED AT THE BOARD OF DIRECTORS MEETINGS AND NOTED IN THE MINUTES. DECLARATIONS OF INTERESTS OF PARTICIPATING BOARD AND COMMITTEE MEMBERS ARE ALSO SHARED AS PART OF THE ADVANCE MATERIAL FOR EACH MEETING. A BOARD MEMBER/ALTERNATE BOARD MEMBER OR COMMITTEE DELEGATE IS EXPECTED TO DISCLOSE ANY REAL/PERCEIVED OR POTENTIAL CONFLICT TO THE CHAIR OF THE BOARD OR THE COMMITTEE, AS SOON AS POSSIBLE UPON LEARNING OF IT AND NO LATER THAN AT THE BEGINNING OF THE DISCUSSION OF THE PERTINENT AGENDA ITEM DURING A BOARD/COMMITTEE MEETING. IT IS THE PREROGATIVE OF THE CHAIR OF THE MEETING, IN CONSULTATION WITH THE GENERAL COUNSEL AND DIRECTOR OF GOVERNANCE, TO DETERMINE THE SCOPE AND LEVEL OF A CONFLICTED PERSON'S PARTICIPATION IN THE DISCUSSION AND THE NECESSITY OF RECUSAL FROM VOTING GIVEN THE TYPE OF INTEREST DISCLOSED. RECUSALS AND/OR ABSTENTIONS FROM ANY DISCUSSIONS AND VOTES ARE NOTED IN THE MINUTES OF THE RELEVANT MEETING. FORM 990, PART VI, SECTION B, LINE 15 GAVI'S COMPENSATION AIMS TO ATTRACT, ENGAGE, REWARD AND RETAIN A TEAM OF HIGH PERFORMING EMPLOYEES WHO ARE DEDICATED TO GAVI'S MISSION. A SYSTEMATIC AND RIGOROUS PROCESS IS SET FOR THE DETERMINATION OF STARTING SALARIES FOR STAFF AT GAVI. KEY CRITERIA FOR ALL POSITIONS INCLUDE THE ASSESSMENT AND SUITABILITY OF THE CANDIDATE AGAINST THE ROLE, INTERNAL EQUITY, AS WELL AS EXTERNAL MARKET COMPETITIVENESS. STARTING SALARIES ARE PREPARED BY THE COMPENSATION AND BENEFITS FUNCTION, APPROVED BY THE CHIEF PEOPLE OFFICER, AND THEN BY THE RESPONSIBLE SENIOR LEADERSHIP MEMBER OR CEO, AS THE CASE MAY BE. GAVI WAS THE FIRST INTERNATIONAL ORGANISATION TO BE CERTIFIED AS EQUAL SALARY CERTIFIED IN 2018, AFTER A RIGOROUS EXTERNAL AUDIT PROCESS WITH THE EQUAL SALARY FOUNDATION IN SWITZERLAND. GAVI CONTINUES TO BE CERTIFIED AS AN EQUAL SALARY EMPLOYER EVERY YEAR SINCE. FORM 990, PART VI, SECTION C, LINE 19 GOVERNANCE DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE POSTED ON THE GAVI ALLIANCE WEBSITE. FORM 1023 AND FEDERAL FORM 990 ARE MADE AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST. FORM 990, PART VII, SECTION A: AN ALTERNATE MEMBER CAN VOTE ONLY WHEN THE CORRESPONDING PRIMARY BOARD MEMBER IS UNABLE TO PARTICIPATE IN VOTING. IF THE PRIMARY BOARD MEMBER IS ABLE TO SUBMIT HIS/HER VOTE THEN THE ALTERNATE MEMBER'S VOTE IS NOT REQUIRED. PART VII LISTS 56 VOTING BOARD MEMBERS. HOWEVER ONLY 33 VOTES COULD BE CAST WHICH ARE PRINCIPAL BOARD MEMBERS. THE 23 ALTERNATE BOARD MEMBERS COULD NOT VOTE UNLESS THEIR ASSOCIATED PRINCIPAL BOARD MEMBER WAS UNAVAILABLE TO VOTE. NONE OF THE ALTERNATE BOARD MEMBER SEATS WERE VACANT. FORM 990, PART XI, LINE 9: RECOVERY OF PRIOR YEAR GRANT 87,171,078. INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY CARPENTER COURT 1 MAPLE ROAD BRAM STOCKPORT CHESHIRE UK SK7 2DH RAISES FUNDS FOR IMMUNIZATION PROGRAMS AND PROCUREMENT UK 501(C)(3) FOREIGN CHARITY GAVI ALLIANCE 1 0 0 1 0 0 0 0 0 0 0 0 1 0 1 1 0 0 0 0 INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY C 365836386 COST INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY L 70979 FMV INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY N 195465 FMV INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY O 883240 FMV